(Q53900332)
Statements
Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors. (English)
K A Gelmon
J Latreille
A Tolcher
L Génier
B Fisher
D Forand
S D'Aloisio
L Vernillet
L Daigneault
A Lebecq
M Besenval
E Eisenhauer
1 December 2000
18
24
4098-4108